| Dr Delana Jean Phillips, MD | |
|
77-311 Sunset Dr, Kailua Kona, HI 96740-9754 | |
| (850) 474-8100 | |
| (850) 474-8083 |
| Full Name | Dr Delana Jean Phillips |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 77-311 Sunset Dr, Kailua Kona, Hawaii |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093731002 | NPI | - | NPPES |
| 080167875 | Other | RAILROAD MEDICARE | |
| 603011900 | Other | FEDERAL WORKERS COMP | |
| 67565 | Other | NC | BCBS |
| 891192E | Medicaid | NC | |
| C2730 | Other | MED COST | |
| 562174647001 | Other | TRICARE |
| Entity Name | Joy A Mcelroy M D Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770610875 PECOS PAC ID: 5698744936 Enrollment ID: O20041001001066 |
News Archive
Malaria affects hundreds of millions of people every year, killing more than half a million. Part of the difficulty of eliminating malaria stems from the fact that a large portion of the at-risk population lives in rural areas where access to doctors can be a challenge.
Crown Bioscience, Inc., a leading global drug discovery and development service company with its R&D centers across the globe has announced that a new partnership agreement has been reached with the National Resource Center for Mutant Mice and its commercial branch Nanjing Biotech Innovation Corporation, in Nanjing, Jiangsu Province, China.
While carotid endarterectomy (CEA) is performed to prevent stroke, long-term survival is essential to ensure benefit, especially in asymptomatic patients. A new study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery today examined patient factors associated with 5-year survival following CEA in patients with asymptomatic internal carotid artery (ICA) stenosis.
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canadian Medical Association Journal).
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Delana Jean Phillips, MD P.o. Box 2508, Kailua Kona, HI 96745-2508 Ph: (850) 474-8100 | Dr Delana Jean Phillips, MD 77-311 Sunset Dr, Kailua Kona, HI 96740-9754 Ph: (850) 474-8100 |
News Archive
Malaria affects hundreds of millions of people every year, killing more than half a million. Part of the difficulty of eliminating malaria stems from the fact that a large portion of the at-risk population lives in rural areas where access to doctors can be a challenge.
Crown Bioscience, Inc., a leading global drug discovery and development service company with its R&D centers across the globe has announced that a new partnership agreement has been reached with the National Resource Center for Mutant Mice and its commercial branch Nanjing Biotech Innovation Corporation, in Nanjing, Jiangsu Province, China.
While carotid endarterectomy (CEA) is performed to prevent stroke, long-term survival is essential to ensure benefit, especially in asymptomatic patients. A new study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery today examined patient factors associated with 5-year survival following CEA in patients with asymptomatic internal carotid artery (ICA) stenosis.
While immediate postexposure treatment for suspected HIV is critical, pre-exposure preventive treatment is a newer method that may be effective for people in high-risk groups, states a review of evidence published in CMAJ (Canadian Medical Association Journal).
Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating orBec (oral beclomethasone 17,21-dipropionate or BDP) as a treatment for the gastrointestinal manifestations of chronic Graft-versus-Host disease.
› Verified 2 days ago
Dr. David Marvin Woodliff, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 75-5751 Kuakini Hwy, Ste 203, Kailua Kona, HI 96740 Phone: 808-326-5629 | |
Dr. Robert Peter Edmonds, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 75-5751 Kuakini Hwy, Suite 101, Kailua Kona, HI 96740 Phone: 808-326-3878 Fax: 808-329-9370 | |
Dr. Stephen Andl, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 75-5751 Kuakini Hwy, Suite 104, Kailua Kona, HI 96740 Phone: 808-326-5629 | |
Dr. Claudia Ann Christman, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 75-5995 Kuakini Hwy, Malama Pono Health Care, Kailua Kona, HI 96740 Phone: 808-345-5054 Fax: 808-329-1917 | |
Dr. Eugene Field Moore, M.D., CFAAFP Family Medicine Medicare: Medicare Enrolled Practice Location: 75-233 Nani Kailua Dr, Unit # 97, Kailua Kona, HI 96740 Phone: 206-915-9855 | |
Greta M Ivers, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 75-5751 Kuakini Hwy Ste 101a, Kailua Kona, HI 96740 Phone: 808-326-5629 |